rVSV-SARS-CoV-2-S vaccine

rVSV-SARS-CoV-2-S vaccine · Israel Institute for Biological Research (IIBR)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rVSV-SARS-CoV-2-S vaccine, covering 2023-11-18 to 2023-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine [Phase 1, Phase 2]